| Style | Citing Format |
|---|---|
| MLA | Hosseinkhannazer N, et al.. "Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results." Human Cell, vol. 34, no. 5, 2021, pp. 1289-1300. |
| APA | Hosseinkhannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M (2021). Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results. Human Cell, 34(5), 1289-1300. |
| Chicago | Hosseinkhannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, Kadri N, Vosough M. "Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results." Human Cell 34, no. 5 (2021): 1289-1300. |
| Harvard | Hosseinkhannazer N et al. (2021) 'Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results', Human Cell, 34(5), pp. 1289-1300. |
| Vancouver | Hosseinkhannazer N, Torabi S, Hosseinzadeh R, Shahrokh S, Asadzadeh Aghdaei H, Memarnejadian A, et al.. Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results. Human Cell. 2021;34(5):1289-1300. |
| BibTex | @article{ author = {Hosseinkhannazer N and Torabi S and Hosseinzadeh R and Shahrokh S and Asadzadeh Aghdaei H and Memarnejadian A and Kadri N and Vosough M}, title = {Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results}, journal = {Human Cell}, volume = {34}, number = {5}, pages = {1289-1300}, year = {2021} } |
| RIS | TY - JOUR AU - Hosseinkhannazer N AU - Torabi S AU - Hosseinzadeh R AU - Shahrokh S AU - Asadzadeh Aghdaei H AU - Memarnejadian A AU - Kadri N AU - Vosough M TI - Novel Cell-Based Therapies in Inflammatory Bowel Diseases: The Established Concept, Promising Results JO - Human Cell VL - 34 IS - 5 SP - 1289 EP - 1300 PY - 2021 ER - |